Search Results - "Richarz, U"

Long-term efficacy and safety of paliperidone 6-month formulation: An open-label extension of a double-blind study in adult patients with schizophrenia by Najarian, D., Turkoz, I., Galderisi, S., Lamaison, H. F., Zalitacz, P., Aravind, S., Richarz, U.

“…Introduction Paliperidone palmitate 6-month (PP6M), administered twice-yearly, demonstrated non-inferiority to paliperidone palmitate 3-month (PP3M) in…”
Get full text

Galantamine treatment in outpatients with mild Alzheimer's disease by Richarz, U., Gaudig, M., Rettig, K., Schauble, B.

“…Objective To assess long‐term effectiveness of galantamine in community‐dwelling persons with mild Alzheimer's disease. Methods Prospective open‐label trial…”
Get full text

The Effect of Longer Dosing Intervals for Long-Acting Injectable Antipsychotics on Outcomes in Schizophrenia by Milz, Ruth, Benson, Carmela, Knight, Karl, Antunes, Jose, Najarian, Dean, Lopez Rengel, Paola-Maria, Wang, Steven, Richarz, Ute, Gopal, Srihari, Kane, John M

“…Medication nonadherence in schizophrenia can have serious implications including relapses and hospitalization. Long-acting injectable (LAI) antipsychotics…”
Get full text

Iontophoretic transdermal system using fentanyl compared with patient-controlled intravenous analgesia using morphine for postoperative pain management by Grond, S., Hall, J., Spacek, A., Hoppenbrouwers, M., Richarz, U., Bonnet, F.

“…The fentanyl iontophoretic transdermal system (fentanyl ITS) enables needle-free, patient-controlled analgesia for postoperative pain management. This study…”
Get full text

Transdermal fentanyl versus sustained release oral morphine in strong-opioid naïve patients with chronic low back pain by ALLAN, Laurie, RICHARZ, Ute, SIMPSON, Karen, SLAPPENDEL, Robert

“…Open, randomized, parallel group multicenter study. To compare the efficacy and safety of transdermal fentanyl (TDF) and sustained release morphine (SRM) in…”
Get full text

Impact of long-term use of opioids on quality of life in patients with chronic, non-malignant pain by Devulder, J., Richarz, U., Nataraja, S. H.

“…ABSTRACT Objective: The use of opioids in the management of non-malignant pain remains controversial. For many physicians, pain relief stemming from opioid use…”
Get full text

Impact of opioid rescue medication for breakthrough pain on the efficacy and tolerability of long-acting opioids in patients with chronic non-malignant pain by Devulder, J., Jacobs, A., Richarz, U., Wiggett, H.

“…There is little evidence that short-acting opioids as rescue medication for breakthrough pain is an optimal long-term treatment strategy in chronic…”
Get full text

Methodological Issues in Conducting Pilot Trials in Chronic Pain as Randomized, Double-blind, Placebo-controlled Studies by Tominaga, Y, Koga, H, Uchida, N, Wanibe, M, Hirose, K, Matsumura, T, Okamoto, A, Richarz, U, Etropolski, M

“…The efficacy of tapentadol extended release (ER) for managing chronic pain has been demonstrated in large-scale, randomized, controlled, phase 3 studies…”
Get more information

Effects of galantamine in Alzheimer's disease: double-blind withdrawal studies evaluating sustained versus interrupted treatment by Gaudig, M, Richarz, U, Han, J, Van Baelen, B, Schäuble, B

“…To evaluate the effects of galantamine withdrawal, and compare this with uninterrupted therapy, two 6-week double-blind withdrawal studies (Studies 1 and 2)…”
Get more information

Two galantamine titration regimens in patients switched from donepezil by Engedal, K., Davis, B., Richarz, U., Han, J., Schäuble, B., Andreasen, N.

“…Engedal K, Davis B, Richarz U, Han J, Schäuble B, Andreasen N. Two galantamine titration regimens in patients switched from donepezil.
Acta Neurol Scand: 2012:…”
Get full text

Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain by Clark, A. J., Ahmedzai, S. H., Allan, L. G., Camacho, F., Horbay, G. L. A., Richarz, U., Simpson, K.

“…SUMMARY Purpose: To evaluate effectiveness and safety information of transdermal fentanyl (TDF) (Duragesic/Durogesic*) and sustained-release oral morphine…”
Get full text

The pharmacokinetics of a long-acting OROS hydromorphone formulation by Turgeon, J, Gröning, R, Sathyan, G, Thipphawong, J, Richarz, U

“…New formulations of opiods can provide round-the-clock pain relief to improve pain management and quality of life for patients with chronic pain. Information…”
Get more information

A comparison of the skin irritation potential of transdermal fentanyl versus transdermal buprenorphine in middle-aged to elderly healthy volunteers by Schmid-Grendelmeier, Peter, Pokorny, Rolf, Gasser, Urs E., Richarz, Ute

“…ABSTRACT Objective: Establishing local tolerability of transdermal opioid systems is important as more systems become available for use in a range of…”
Get full text

Transdermal fentanyl for the treatment of pain caused by osteoarthritis of the knee or hip: an open, multicentre study by Le Loët, Xavier, Pavelka, Karel, Richarz, Ute

“…This study was designed to evaluate the utility of transdermal fentanyl (TDF, Durogesic) for the treatment of pain due to osteoarthritis (OA) of the knee or…”
Get full text

Successful treatment and prophylaxis of scalp seborrhoeic dermatitis and dandruff with 2% ketoconazole shampoo: results of a multicentre, double-blind, placebo-controlled trial by Peter, R U, Richarz-Barthauer, U

“…Pityrosporum ovale appears to play an important role in the pathogenesis of seborrhoeic dermatitis. Ketoconazole is an antimycotic agent with a high in vitro…”
Get more information

Benefits of transdermal fentanyl in patients with rheumatoid arthritis or with osteoarthritis of the knee or hip: an open-label study to assess pain control by Pavelka, Karel, Loet, Xavier Le, Bjorneboe, Olav, Herrero-Beaumont, Gabriel, Richarz, Ute

“…SUMMARY Objectives: To evaluate the effectiveness and safety of transdermal fentanyl (TDF) for the treatment of pain associated with rheumatoid arthritis (RA)…”
Get full text

651P Impact of abiraterone acetate plus prednisone (AAP) in patients with castration-sensitive prostate cancer (mCSPC) and visceral metastases: Subgroup analyses of the LATITUDE study by Baciarello, G., Ozguroglu, M., Mundle, S.D., Leitz, G., Richarz, U., Hu, P., Chi, K.N., Fizazi, K.

Get full text

Efficacy and Safety of Paliperidone Palmitate 6-Month versus Paliperidone Palmitate 3-Month Long-Acting Injectable in European Patients with Schizophrenia: A Post Hoc Analysis of a Global Phase-3 Double-Blind Randomized Non-Inferiority Study by Giron-Hernandez, Cesar, Han, Joong Hee, Alberio, Roberta, Singh, Arun, García-Portilla, Maria Paz, Pompili, Maurizio, Knight, R Karl, Richarz, Ute, Gopal, Srihari, Antunes, José

“…To examine efficacy and safety of paliperidone palmitate (PP) 6-month (PP6M) vs PP3-month (PP3M) long acting injectable (LAI) in patients with schizophrenia…”
Get full text

End-of-Dose Pain in Chronic Pain: Does it Vary with the Use of Different Long-Acting Opioids? by Zimmermann, Michael, Richarz, Ute

“…A large percentage of patients with chronic pain on around‐the‐clock (ATC) opioids may experience increased pain occurring at the end of a scheduled dose, also…”
Get full text

PF646 ASSOCIATION BETWEEN BORTEZOMIB CUMULATIVE DOSE AND TREATMENT‐FREE INTERVAL IN TRANSPLANT‐INELIGIBLE PATIENTS WITH PREVIOUSLY UNTREATED MULTIPLE MYELOMA by Paz‐Filho, G., Hu, P., Nemat, S., Appiani, C., Lam, A., Richarz, U., He, J.

“…Background: The phase III VISTA study has demonstrated that bortezomib‐melphalan‐prednisone (VMP) leads to improved clinical outcomes, such as significant…”
Get full text